摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Propenoic acid, 2-methyl-, 2-[4-[1-methyl-1-[4-[2-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethoxy]ethoxy]phenyl]ethyl]phenoxy]ethyl ester | 65133-66-6

中文名称
——
中文别名
——
英文名称
2-Propenoic acid, 2-methyl-, 2-[4-[1-methyl-1-[4-[2-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethoxy]ethoxy]phenyl]ethyl]phenoxy]ethyl ester
英文别名
2-[2-[4-[2-[4-[2-(2-methylprop-2-enoyloxy)ethoxy]phenyl]propan-2-yl]phenoxy]ethoxy]ethyl 2-methylprop-2-enoate
2-Propenoic acid, 2-methyl-, 2-[4-[1-methyl-1-[4-[2-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethoxy]ethoxy]phenyl]ethyl]phenoxy]ethyl ester化学式
CAS
65133-66-6
化学式
C29H36O7
mdl
——
分子量
496.6
InChiKey
NGFFKUHICVFZTR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.2
  • 重原子数:
    36
  • 可旋转键数:
    17
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    80.3
  • 氢给体数:
    0
  • 氢受体数:
    7

文献信息

  • Polymer Materials With Unsaturated Transfer Reagents
    申请人:Ivoclar Vivadent AG
    公开号:US20200087241A1
    公开(公告)日:2020-03-19
    Radically polymerizable composition which contains at least one vinyl ether according to general formula I: in which the variables have the following meanings: A is H, CN, a cycloaliphatic, linear or branched aliphatic C 1 -C 30 hydrocarbon residue, an aromatic C 6 -C 30 hydrocarbon residue or a combination thereof; X is —COO—, —CON(R 3 )— or is dispensed with; B is H, CN, a cycloaliphatic, linear or branched aliphatic C 1 -C 30 hydrocarbon residue, an aromatic C 6 -C 30 hydrocarbon residue or a combination thereof; Y is —COO—, —CON(R 3 )— or is dispensed with; R 1-3 in each case independently of one another are hydrogen, a cycloaliphatic, linear or branched aliphatic C 1 -C 10 hydrocarbon residue or an aromatic C 6 -C 10 hydrocarbon residue; m is an integer from 1 to 6; n is an integer from 1 to 6; p is an integer from 1 to 6; wherein m and p cannot be greater than 1 at the same time and wherein if m=1, p=n, and if p=1, m=n.
    包含至少一种根据通式I的乙烯醚的根本聚合组合物:其中变量具有以下含义:A为H、CN、环脂肪、线性或支链脂肪C1-C30烃残基、芳香族C6-C30烃残基或它们的组合;X为—COO—、—CON(R3)—或省略;B为H、CN、环脂肪、线性或支链脂肪C1-C30烃残基、芳香族C6-C30烃残基或它们的组合;Y为—COO—、—CON(R3)—或省略;R1-3分别独立地为、环脂肪、线性或支链脂肪C1-C10烃残基或芳香族C6-C10烃残基;m为1到6的整数;n为1到6的整数;p为1到6的整数;其中m和p不能同时大于1,如果m=1,则p=n,如果p=1,则m=n。
  • Dental Materials Based On Cyclopolymerizable Crosslinkers
    申请人:Ivoclar Vivadent AG
    公开号:US20210236388A1
    公开(公告)日:2021-08-05
    Dental material which comprises at least one compound of formula I, in which R 1 is a linear, branched or cyclic aliphatic C 1 -C 30 hydrocarbon radical or an aromatic C 6 -C 30 hydrocarbon radical, wherein the aliphatic or aromatic hydrocarbon radical can be substituted or unsubstituted and wherein aliphatic hydrocarbon radicals can be interrupted by one or more urethane groups, ester groups, oxygen atoms and/or sulfur atoms; X, Y, Z independently of each other in each case are -COOR 2 —, -CON(R 3 R 4 )—, an aromatic C 6 -C 10 hydrocarbon radical or CN, wherein R 2 , R 3 , R 4 in each case independently of each other is hydrogen, a linear, branched or cyclic aliphatic C 1 -C 30 hydrocarbon radical or an aromatic C 6 -C 30 hydrocarbon radical, wherein the aliphatic or aromatic hydrocarbon radical can be substituted or unsubstituted and wherein aliphatic hydrocarbon radicals can be interrupted by one or more oxygen atoms, and m is 2 or 3.
    牙科材料,其中至少包含一种符合以下式I的化合物,其中R1是线性、支链或环状脂肪族C1-C30碳氢化合物基团或芳香族C6-C30碳氢化合物基团,其中脂肪族或芳香族基团可以是取代的或未取代的,脂肪基团可以被一个或多个基团、基团、原子和/或原子中断;X、Y、Z分别独立地分别为-COOR2—、-CON(R3R4)—、芳香族C6-C10碳氢化合物基团或CN,其中R2、R3、R4分别独立地为、线性、支链或环状脂肪族C1-C30碳氢化合物基团或芳香族C6-C30碳氢化合物基团,其中脂肪族或芳香族基团可以是取代的或未取代的,脂肪基团可以被一个或多个原子中断,m为2或3。
  • Dental Materials Based On Redox Systems With Low-Odour Cumene Hydroperoxide Derivatives
    申请人:Ivoclar Vivadent AG
    公开号:US20200253837A1
    公开(公告)日:2020-08-13
    Radically polymerizable dental material, which contains a combination of a thiourea derivative and a hydroperoxide according to the following Formula (I) as initiator system for the radical polymerization:
    具有以下公式(I)中的硫脲生物过氧化氢的组合的根本聚合牙科材料,作为自由基聚合的引发体系。
  • Dental Materials Based On Low-Viscosity Radically Polymerizable Monomers With A High Refractive Index
    申请人:Ivoclar Vivadent AG
    公开号:US20190015301A1
    公开(公告)日:2019-01-17
    Radically polymerizable, difunctional phenylene sulfide according to Formula I in which X, Y independently of each other in each case are absent or are O or NR 6 , R 1 , R 2 independently of each other in each case are H, a linear or branched C 1 to C 10 alkyl radical, —OR 7 , —SR 8 , Cl or Br, R 3 is absent or is a C 1 -C 10 alkylene radical which can be interrupted by O or S, R 4 is absent or is a C 1 -C 10 alkylene radical which can be interrupted by O or S, wherein R 3 and R 4 cannot be absent at the same time, R 5 is H or a C 1 -C 5 alkyl radical, R 6 , R 7 , R 8 independently of each other in each case are H or a linear or branched C 1 to C 10 alkyl radical, a, b, c, d independently of each other in each case are 0 or 1 and e is 1 or 2.
    根据以下公式I,根据以下公式I,根据以下公式I,根据以下公式I,可进行根本聚合的二官能硫化物,其中X、Y在每种情况下独立地不存在或为O或NR6,R1、R2在每种情况下独立地为H、线性或支链的C1至C10烷基基团,-OR7,-SR8,Cl或Br,R3不存在或为可以被O或S中断的C1-C10烷基基团,R4不存在或为可以被O或S中断的C1-C10烷基基团,其中R3和R4不能同时不存在,R5为H或C1-C5烷基基团,R6、R7、R8在每种情况下独立地为H或线性或支链的C1至C10烷基基团,a、b、c、d在每种情况下独立地为0或1,e为1或2。
  • Polymerizable Materials Based On Dimerizable Benzaldehyde Derivatives
    申请人:Ivoclar Vivadent AG
    公开号:US20200079888A1
    公开(公告)日:2020-03-12
    The present invention relates to polymerizable and photochemically crosslinkable compositions which contain at least one polymerizable benzaldehyde derivative according to general formula I and which are suitable as materials for technical and medical applications, for example in surgery or ophthalmology, and in particular as dental materials.
    本发明涉及可聚合和光化学交联的组合物,其中包含至少一种根据一般式I的聚合物苯甲醛生物,适用于技术和医学应用的材料,例如在外科手术或眼科中,特别是作为牙科材料。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫